Cardio-oncology: the role of advanced echocardiography in cancer patients

References

• Yeh ET, Bickford CL. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol. 2009;53:2231–2247.
   PubMed Web of Science ®Google Scholar
• Ky B, Vejpongsa P, Yeh ET, et al. Emerging paradigms in cardiomyopathies associated with cancer therapies. Circ Res. 2013;113:754–764.
   PubMed Web of Science ®Google Scholar
• Lancellotti P, Nikomo VT, Badano LP et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from European Association of Cardiovascular Imaging and American Society of Echocardiography. Eur Heart J Cardiovasc Imaging. 2013;14:721–740.
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;2016(37):2129–2200.
   Web of Science ®Google Scholar
• National Cancer Institute. Common terminology criteria for adverse events (CTCAE). Version 4.0. [cited 2014 Aug 11]. Available from: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf
   Google Scholar
• Plana JC, Galderisi M, Barac A, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy. A report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2014;15:1063–1093.
   PubMed Web of Science ®Google Scholar
• Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233–270.
   PubMed Web of Science ®Google Scholar
• Cardinale D, Colombo A, Bacchiani G, et al. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 2015;131:1981–1988.
   PubMed Web of Science ®Google Scholar
• Ewer MS, Vooletich MT, Durand JB, et al. Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment. J Clin Oncol. 2005;23:7820–7826.
   PubMed Web of Science ®Google Scholar
• Hall PS, Harshman LC, Srinivas S, et al. The frequency and severity of cardiovascular toxicity from targeted therapy in advanced renal cell carcinoma patients. JACC Heart Fail. 2013;1:72–78.
   PubMed Web of Science ®Google Scholar
• Cardinale D, Colombo A, Lamantia G, et al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol. 2010;55:213–220.
   PubMed Web of Science ®Google Scholar
• Schwartz RG, McKenzie WB, Alexander J, et al. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography. Am J Med. 1987;82:1109–1118.
   PubMed Web of Science ®Google Scholar
• Einstein AJ, Berman DS, Min JK, et al. Patient-centered imaging: shared decision making for cardiac imaging procedures with exposure to ionizing radiation. J Am Coll Cardiol. 2014;63:1480–1489.
   PubMed Web of Science ®Google Scholar
• Walker J, Bhullar N, Fallah-Rad N, et al. Role of three- dimensional echocardiography in breast cancer: comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging. J Clin Oncol. 2010;28:3429–3436.
   PubMed Web of Science ®Google Scholar
• Senior R, Becher H, Monaghan M, et al. Clinical practice of contrast echocardiography: recommendation by the European Association of Cardiovascular Imaging (EACVI) 2017. Eur Heart J Cardiovasc Imaging. 2017;18:1205-1205af. doi: 10.1093/ehjci/jex182.
   Web of Science ®Google Scholar
• Thavendiranathan P, Grant AD, Negishi T, et al. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J Am Coll Cardiol. 2013;61:77–84.
   PubMed Web of Science ®Google Scholar
• Ewer MS, Ali MK, Mackay B, et al. A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin. J Clin Oncol. 1984;2:112–117.
   PubMed Web of Science ®Google Scholar
• Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer. 2003;97:2869–2879.
   PubMed Web of Science ®Google Scholar
• Mor-Avi V, Lang RM, Badano LP, et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur J Echocardiogr. 2011;12:167–205.
   PubMed Web of Science ®Google Scholar
• Yu CM, Sanderson JE, Marwick TH, et al. Tissue Doppler imaging a new prognosticator for cardiovascular diseases. J Am Coll Cardiol. 2007;49:1903–1914.
   PubMed Web of Science ®Google Scholar
• Ganame J, Claus P, Eyskens B, et al. Acute cardiac functional and morphological changes after Anthracycline infusions in children. Am J Cardiol. 2007;99:974–977.
   PubMed Web of Science ®Google Scholar
• Ho E, Brown A, Barrett P, et al. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study. Heart. 2010;96:701–707.
   PubMed Web of Science ®Google Scholar
• Fallah-Rad N, Walker JR, Wassef A, et al. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy. J Am Coll Cardiol. 2011;57:2263–2270.
   PubMed Web of Science ®Google Scholar
• Sawaya H, Sebag IA, Plana JC, et al. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging. 2012;5:596–603.
   PubMed Web of Science ®Google Scholar
• Stoodley PW, Richards DA, Hui R, et al. Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy. Eur J Echocardiogr. 2011;12:945–952.
   PubMed Web of Science ®Google Scholar
• Thavendiranathan P, Poulin F, Lim KD, et al. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy - a systematic review. J Am Coll Cardiol. 2014;63:2751–2768.
   PubMed Web of Science ®Google Scholar
• Migrino RQ, Aggarwal D, Konorev E, et al. Early detection of doxorubicin cardiomyopathy using two-dimensional strain echocardiography. Ultrasound Med Biol. 2008;34:208–214.
   PubMed Web of Science ®Google Scholar
• Negishi K, Negishi T, Hare JL, et al. Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity. J Am Soc Echocardiogr. 2013;26:493–498.
   PubMed Web of Science ®Google Scholar
• Yingchoncharoen T, Agarwal S, Popović ZB, et al. Normal ranges of left ventricular strain: a meta-analysis. J Am Soc Echocardiogr. 2013;26:185–191.
   PubMed Web of Science ®Google Scholar
• Mornos C, Petrescu L. Early detection of anthracycline-mediated cardiotoxicity: the value of considering both global longitudinal left ventricular strain and twist. Can J Physiol Pharmacol. 2013;91:601–607.
   PubMed Web of Science ®Google Scholar
• Wang J, Khoury DS, Thohan V, et al. Global diastolic strain rate for the assessment of left ventricular relaxation and filling pressures. Circulation. 2007;115:1376–1383.
   PubMed Web of Science ®Google Scholar
• Stoddard MF, Seeger J, Liddell NE, et al. Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans. J Am Coll Cardiol. 1992;20:62–69.
   PubMed Web of Science ®Google Scholar
• Lanzarini L, Bossi G, Laudisa ML, et al. Lack of clinically significant cardiac dysfunction during intermediate dobutamine doses in long-term childhood cancer survivors exposed to anthracyclines. Am Heart J. 2000;140:315–323.
   PubMed Web of Science ®Google Scholar
• Weesner KM, Bledsoe M, Chauvenet A, et al. Exercise echocardiography in the detection of anthracycline cardiotoxicity. Cancer. 1991;68:435–438.
   PubMed Web of Science ®Google Scholar
• Khouri MG, Hornsby WE, Risum N, et al. Utility
of 3-dimensional echocardiography, global longitudinal strain, and exercise stress echocardiography to detect cardiac dysfunction in breast cancer patients treated with doxorubicin-containing adjuvant therapy. Breast Cancer Res Treat. 2014;143:531–539.
   PubMed Web of Science ®Google Scholar
• Ryerson AB, Border WL, Wasilewski-Masker K, et al. Assessing anthracycline- treated childhood cancer survivors with advanced stress echocardiography. Pediatric Blood and Cancer. 2015;62:502–508.
   PubMed Web of Science ®Google Scholar
• Hamada H, Ohkubo T, Maeda M. et al. Evaluation
of cardiac reserved function by high-dose dobutamine-stress echocardiography in asymptomatic anthracycline-treated survivors of childhood cancer. Pediatrics Int. 2006;48:313–320.
   PubMed Web of Science ®Google Scholar
• Bountioukos MI, Doorduijn JK, Roelandt JR, et al. Repetitive dobutamine stress echocardiography for the prediction of anthracycline cardiotoxicity. Eur J Echocardiogr. 2003;4:300–305.
   PubMedGoogle Scholar
• Civelli M, Cardinale D, Martinoni A, et al. Early reduction in left ventricular contractile reserve detected by dobutamine stress echo predicts high-dose chemotherapy-induced cardia toxicity. Int J of Cardiol. 2006;111:120–126.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Khattar RS, Gujral DM, et al. Cardiac tumors: the role of cardiovascular imaging. Expert Rev Cardiovasc Ther. 2014;12:37–43.
   PubMedGoogle Scholar
• Lestuzzi C. Neoplastic pericardial disease: old and current strategies for diagnosis and management. World J Cardiol. 2010;2:270–279.
   PubMedGoogle Scholar
• Tanindi A, Demirci U, Tacoy G, et al. Assessment of right ventricular functions during cancer chemotherapy. Eur J Echocardiogr. 2011;12:834–840.
   PubMed Web of Science ®Google Scholar
• Boczar KE, Aseyev O, Sulpher J, et al. Right heart function deteriorates in breast cancer patients undergoing anthracycline-based chemotherapy. Echo Res Pract. 2016;3:79–84.
   PubMed Web of Science ®Google Scholar
• Calleja A, Poulin F, Khorolsky C, et al. Right ventricular dysfunction in patients experiencing cardiotoxicity during breast cancer therapy. J Oncol. 2015;2015:609194. doi: 10.1155/2015/609194.
   Web of Science ®Google Scholar
• Belham M, Kruger A, Pritchard C. The Tei index identifies a differential effect on left and right ventricular function with low-dose anthracycline chemotherapy. J Am Soc Echocardiogr. 2006;19:206–210.
   PubMed Web of Science ®Google Scholar
• Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23:685–71340.
   PubMed Web of Science ®Google Scholar
• Chang WT, Shih JY, Feng YH, et al. The early predictive value of right ventricular strain in epirubicin-induced cardiotoxicity in patients with breast cancer. Acta Cardiol Sin. 2016;32:550–559.
   PubMed Web of Science ®Google Scholar
• Armenian SH, Lacchetti C, Barac A, et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2017;35:893–911.
   PubMed Web of Science ®Google Scholar
• Children’s Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers, version 3.0 (Children’s Oncology Group website). 2008. Available from: http://www.survivorshipguidelines.org
   Google Scholar
• El-Shami K, Griffiths E, Streiff M. Non-bacterial thrombotic endocarditis in cancer patients: pathogenesis, diagnosis, and treatment. Oncologist. 2007;12:518–523.
   PubMed Web of Science ®Google Scholar
• Cardinale D, Sandri MT. Role of biomarkers in chemotherapy-induced cardiotoxicity. Prog Cardiovasc Dis. 2010;53:121–129.
   PubMed Web of Science ®Google Scholar
• Dang CT, Yu AF, Jones LW, et al. Cardiac surveillance guidelines for trastuzumab-containing therapy in early-stage breast cancer: getting to the heart of matter. Clin Oncol. 2016;34:1030–1033.
   Web of Science ®Google Scholar
• Yeh JM, Nohria A, Diller L. Routine echocardiography screening for asymptomatic left ventricular dysfunction in childhood cancer survivors: a model-based estimation of the clinical and economic effects. Ann Intern Med. 2014;160:661–671.
   PubMed Web of Science ®Google Scholar
• Nolan MT, Plana JC, Thavendiranathan P, et al. Cost-effectiveness of strain-targeted cardioprotection for prevention of chemotherapy-induced cardiotoxicity. Int J Cardiol. 2016;212:336–345.
   PubMed Web of Science ®Google Scholar
• Negishi T, Negishi K, Thavendiranathan P, et al.; SUCCOUR Investigators. Effect of experience and training on the concordance and precision of strain measurements. JACC Cardiovasc Imaging. 2017;10:518–522.
   PubMed Web of Science ®Google Scholar